Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China flag China · Delayed Price · Currency is CNY
51.18
+1.19 (2.38%)
Apr 25, 2025, 2:45 PM CST

Betta Pharmaceuticals Company Description

Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China.

The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer.

The company was founded in 2003 and is headquartered in Hangzhou, China.

Betta Pharmaceuticals Co., Ltd.
Country China
Founded 2003
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,961
CEO Lieming Ding

Contact Details

Address:
No. 355, Xingzhong Road
Hangzhou, 311100
China
Phone 86 57 1892 65665
Website bettapharma.com

Stock Details

Ticker Symbol 300558
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100002DD9
SIC Code 2834

Key Executives

Name Position
Dr. Lieming Ding Founder, Chairman of the Board, Chief Executive Officer and GM
Jianxun Fan Vice President, Chief Financial Officer and Director
Jiang Wan Senior Vice President, Chief Operating Officer and Director
Jia Tong Chief Administrative Officer and Director
Yangnan Zhang Chairman of the Supervisory Board and Senior Director of Project Declaration
Fei Wu Supervisor and Senior Director of Internal Control Affairs
Lingxi Wu Board Secretary and Head of Chairman Office
Dr. Mao Li President of Research & Development and Chief Medical Officer